US LNG exports surge but will buyers in China turn up?
NEW YORK/BELFAST/LONDON - Diaceutics PLC (AIM:LON:DXRX), a technology and solutions provider to pharmaceutical and biotech industries, announced Tuesday the appointment of Lauren DeWitt as Executive Vice President, Legal, General Counsel, and Group Company Secretary.
DeWitt will be based at the company’s U.S. headquarters and brings legal experience from the pharmaceutical sector. She previously served as Vice President and Head of General Legal at Sandoz (SIX:SDZ), where she led a team of senior attorneys supporting various aspects of the U.S. business.
Prior to Sandoz, DeWitt held legal roles at Novartis (SIX:NOVN), including Global Head of Legal BD&L for Novartis Group, overseeing global transactions and strategic partnerships. She began her career as a litigator representing healthcare and life sciences companies.
Ryan Keeling, Chief Executive Officer of Diaceutics, said DeWitt’s "deep expertise across litigation, regulatory, and transactional legal functions, along with a strategic mindset" aligns with the company’s growth plans.
"I’m thrilled to be joining Diaceutics at such an exciting stage of its journey," DeWitt said in the press release statement.
Diaceutics, which is listed on London’s AIM market, provides technology and solutions to pharmaceutical and biotech companies.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.